经颈静脉肝内门体分流术(TIPS)单独与联合部分脾栓塞术(PSE)治疗静脉曲张出血的比较
回顾性纳入48例接受TIPS置入的患者,分为TIPS+PSE组(n=16)与TIPS组(n=32),比较两组长期分流道通畅率与总生存率;TIPS+PSE组5年累积原发通畅率显著高于TIPS组(56.8% vs. 32.8%,p=0.028),但5年累积继发通畅率与总生存率两组无显著差异。
要点
- TIPS联合PSE组5年累积原发通畅率56.8%,高于TIPS单用组的32.8%(p=0.028)。
- 两组5年累积继发通畅率(93.8% vs. 87.7%,p=0.749)与总生存率(62.5% vs. 30.7%,p=0.414)无显著差异。
- 分流道功能障碍的独立预测因素包括分组、门静脉压力下降及基线门静脉血栓。
核心结论
- 同期联合PSE可能有助于提高TIPS术后长期原发分流道通畅率,但未提高总生存率;作者认为需进一步前瞻性研究验证这些回顾性发现并探究潜在机制。
研究设计与样本
- 回顾性研究,纳入48例接受TIPS置入的患者,分为TIPS+PSE组(n=16)与TIPS组(n=32),分别接受TIPS联合PSE治疗与TIPS单独治疗。
诊断标准与关键数值
- 5年累积原发通畅率:TIPS+PSE组56.8% vs. TIPS组32.8%(p=0.028)。
- 5年累积继发通畅率:TIPS+PSE组93.8% vs. TIPS组87.7%(p=0.749)。
- 总生存率:TIPS+PSE组62.5% vs. TIPS组30.7%(p=0.414)。
- 分流道功能障碍的Cox回归预测因素:分组(HR 0.235,95%CI 0.084-0.665,p=0.006)、门静脉压力下降(HR 0.687,95%CI 0.563-0.838,p=0.000)、基线门静脉血栓(HR 3.955,95%CI 1.634-9.573,p=0.002)。
- 死亡的Cox回归预测因素:腹水(HR 2.941,95%CI 1.250-6.920,p=0.013)。
临床应用与阅片要点
- 原文结论指出同期联合PSE可能有助于提高TIPS术后长期原发分流道通畅率,但未提高总生存率。
- TIPS+PSE组除潜在脾脓肿发生风险外,两组均未观察到严重不良事件。
- 作者认为需进一步前瞻性研究验证这些回顾性发现并探究潜在机制。
局限性
- 原文结论指出需进一步前瞻性研究验证这些回顾性发现。
- 原文结论指出需进一步研究以探究潜在机制。
- 原文指出TIPS+PSE组存在潜在脾脓肿发生风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Transjugular intrahepatic portosystemic shunt (TIPS) and partial splenic embolization (PSE) were two interventional radiological treatments for the complications of cirrhosis. This study aimed to investigate the effects of concomitant PSE on the long-term shunt patency and overall survival of TIPS-treated patients.
METHODS: Forty-eight patients with TIPS insertion were enrolled and studied retrospectively. They were divided into TIPS+PSE (n = 16) and TIPS groups (n = 32), undergoing combined therapy using TIPS and PSE, and monotherapy using TIPS alone, respectively.
RESULTS: The 5-year cumulative primary patency rate in the TIPS+PSE group was markedly higher than in the TIPS group (56.8% vs. 32.8%, p = 0.028), whereas the 5-year cumulative secondary patency rate (93.8% vs. 87.7%, p = 0.749) and overall survival rate (62.5% vs. 30.7%, p = 0.414) were not significantly different between the two groups. Cox-regression models revealed that group (hazard ratio [HR], 0.235; 95% CI, 0.084-0.665; p = 0.006), portal venous pressure decline (HR, 0.687; 95% CI, 0.563-0.838; p = 0.000), and baseline portal vein thrombosis (HR, 3.955; 95% CI, 1.634-9.573; p = 0.002) were significant predictors for shunt dysfunction, while only ascites (HR, 2.941; 95% CI, 1.250-6.920; p = 0.013) was a significant predictor for mortality. No severe adverse event was noted in the two groups except for the potential risk of splenic abscess development in the TIPS+PSE group.
CONCLUSIONS: Concomitant PSE may help increase the long-term primary shunt patency rate, but not the overall survival of TIPS-treated patients. Further prospective studies are needed to validate these retrospective findings and to investigate the potential mechanisms.
KEY POINTS: • Combined therapy using TIPS and PSE is associated with higher primary patency rates than TIPS alone. • Combined therapy using TIPS and PSE is associated with similar rates of secondary patency and overall survival of patients than TIPS alone. • Group (TIPS alone or TIPS+PSE), PVD, and baseline PVT are three independent predictors for shunt dysfunction, while ascites is the only independent predictor for mortality.
引用
- Wan YM, Li YH, Xu ZY, et al. Comparison of TIPS alone and combined with partial splenic embolization (PSE) for the management of variceal bleeding. Eur Radiol. 2019. PMID: 30796573. doi:10.1007/s00330-019-06046-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。